Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.17	17.95	5.09	24.57	38.45
Short-Term Investments	0.3	48.82	108.1	226.04	-
Cash & Short-Term Investments	9.48	66.77	113.19	250.61	38.45
Cash Growth	-85.81%	-41.01%	-54.84%	551.80%	122.10%
Accounts Receivable	4.75	9.32	7.02	4.93	2.78
Other Receivables	0.02	0.34	0.47	-	-
Receivables	4.77	9.66	7.5	4.93	2.78
Inventory	11.12	22.89	29.76	12.39	3.32
Prepaid Expenses	0.7	1.1	1.39	4.48	0.64
Other Current Assets	13.42	39.69	5.47	-	1.61
Total Current Assets	39.49	140.12	157.3	272.41	46.79
Property, Plant & Equipment	24.32	32.48	28.96	20.94	4.91
Goodwill	-	-	77.29	56.16	7.17
Other Intangible Assets	9.71	33.97	41.14	26.84	1.48
Other Long-Term Assets	3.15	7.83	2.81	0.75	0.1
Total Assets	76.67	214.4	307.5	377.1	60.45
Accounts Payable	6.96	10.38	12.53	10.77	2.93
Accrued Expenses	4.62	6.58	9.22	6.94	4.36
Short-Term Debt	20.36	69.8	-	-	-
Current Portion of Leases	3.25	2.44	2.55	1.77	-
Current Income Taxes Payable	0.73	1.1	0.83	0.68	0.56
Current Unearned Revenue	1.13	0.78	0.87	0.68	0.42
Other Current Liabilities	0.29	8.94	9.89	1	0.68
Total Current Liabilities	37.34	100.03	35.88	21.84	8.95
Long-Term Debt	-	-	-	-	16.33
Long-Term Leases	3.68	7.18	9.12	8.93	-
Long-Term Unearned Revenue	0.27	0.15	0.13	0.15	0.1
Other Long-Term Liabilities	-	10.89	12.97	9.07	-
Total Liabilities	41.3	118.25	58.1	39.98	25.37
Common Stock	-	-	0	0.03	0.02
Additional Paid-In Capital	728.57	677.34	599.23	553.75	178.75
Retained Earnings	-693.23	-581.21	-348.72	-216.12	-143.68
Comprehensive Income & Other	0.03	0.02	-1.12	-0.54	-
Total Common Equity	35.38	96.16	249.4	337.12	35.08
Shareholders' Equity	35.38	96.16	249.4	337.12	35.08
Total Liabilities & Equity	76.67	214.4	307.5	377.1	60.45
Total Debt	27.3	79.41	11.67	10.7	16.33
Net Cash (Debt)	-17.82	-12.64	101.52	239.92	22.12
Net Cash Growth	-	-	-57.69%	984.42%	-
Net Cash Per Share	-14.02	-22.22	210.61	520.08	127.33
Filing Date Shares Outstanding	3.01	0.91	0.51	0.48	0.46
Total Common Shares Outstanding	1.87	0.76	0.5	0.48	0.32
Working Capital	2.15	40.09	121.41	250.57	37.84
Book Value Per Share	18.96	126.10	503.52	698.44	110.81
Tangible Book Value	25.67	62.18	130.97	254.12	26.43
Tangible Book Value Per Share	13.76	81.55	264.41	526.48	83.50
Machinery	42.76	38.68	27.11	16.72	10.48
Leasehold Improvements	3.33	3.75	4	2.67	1.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.